Immunoassay analyzers are used to measure the concentration of analytes in blood samples using antigen-antibody binding properties. According to a recent report from Market Research Future, the global immunoassay analyzers market is growing steadily at a CAGR of 15.6% during the forecast period 2017-2023.
The global market for immunoassay analyzers is driven by factors such as
- increasing prevalence of different infectious, immunological or metabolic diseases
- increasing demand for advanced diagnostic devices, automation and integration
- increasing geriatric population and changing lifestyles
- growing prevalence of smoking and drinking
- increased spending on healthcare
- rising number of people suffering from cardiovascular disease and diabetes
However, the report notes that test and assays performed are strictly monitored, and rigorous regulatory requirements and high cost of the instruments may hinder this market's growth.
The report divides the market on the basis of instruments, applications, and end users. On the basis of instruments, the market is segregated into immunofluorescence, chemiluminescence, ELISA, enzyme linked fluorescent systems, multiplexed assay systems, radioimmunoassay, and others. Categories based on application include infectious diseases, autoimmune diseases, AIDS, endocrinology, drug monitoring, cardiology, oncology, allergy testing and others. The end users of this market are hospitals, diagnostic laboratories, research institutes, etc.
Region-wise, the market is dominated by America, followed by Europe. Factors such as large patient population, strong government support, increasing diabetic population, changing lifestyles, and increasing healthcare expenditure has contributed to the growth of the market in America. Asia Pacific is the fastest growing region for the market due to the presence of rapidly developing economies and increasing need for better treatment.
The report lists the key players in the global immunoassay analyzer market as: F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), Immunodiagnostic Systems (UK), Merck KGaA (US), Olympus Corporation (Japan), Thermo Fisher Scientific (US), DiaSorin S.p.A. (Italy) and Randox Laboratories Ltd. (UK).